Sterile Injectable Drugs market is driven by increasing prevalence of chronic diseases such as cardiovascular disease, diabetes globally. Also, growing investment in R&D by major market players for developing disease-specific drugs is projected to boost the growth of the global market over the forecast period. Furthermore, the rising number for drug approvals by the health authority for injectable and subsequently successful commercialization and launching of innovative drugs is anticipated to further propel the growth of the global market over the forecast period.

Sterile injectable drugs market was valued at US$ 706.9 Billion in 2024 and is projected to grow at a CAGR of 4.70% to reach US$ 1077.1 Billion by 2034.

The report "Sterile Injectable Drugs Market, By Type (Small Molecule and Large Molecule), By Therapeutic Application (Cancer, Diabetes, Cardiovascular Diseases, Infectious Disorders, Central Nervous Systems, Musculoskeletal, Anti-Viral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region - Global Forecast to 2034"

Key Highlights:

• On 6^th January 2020, AstraZeneca declared the U.S Food and Drug Administration (FDA) established a supplemental New Drug Application (sNDA) and granted Priority Review for Farxiga (dapagliflozin). To reduce the risk of cardiovascular (CV) death or the worsening of heart failure (HF) in adults with heart failure with reduced ejection fraction (HFrEF) with and without type-2 diabetes (T2D).
• On July 2018, Pfizer announced to grow its commitment to U.S. manufacturing with a US$465 million investment to build one of the most technically advanced sterile injectable pharmaceutical production facilities in the world in Portage, Michigan. This investment within the U.S. will build up Pfizer’s capability to produce and supply critical, life-saving injectable medicines for patients worldwide.

Key Market Insights from the report:          

Sterile injectable drugs market was valued at US$ 706.9 Billion in 2024 and is projected to grow at a CAGR of 4.70% to reach US$ 1077.1 Billion by 2034.The market report has been segmented based on type, therapeutic application, distribution channel, and region.

• By type, the global sterile injectable drugs market is segmented into small molecule and large molecule. In 2019, the large molecule type segment is dominating the target market and is expected to maintain its position over the forecast period.
• By therapeutic application, the global market is segmented into cancer, diabetes, cardiovascular diseases, infectious disorders, central nervous systems, musculoskeletal, anti-viral, and others
• By therapeutic application, the global market is segmented into cancer, diabetes, cardiovascular diseases, infectious disorders, central nervous systems, musculoskeletal, anti-viral, and others
• By region, Asia-Pacific is accounted to register the highest rate of growth in the sterile injectable drugs market. This is mainly attributed due to the presence of a large patient pool, rising awareness about sterile injectable drugs, presence of various small pharma companies in India and China, and the introduction of different types of policies by various government bodies.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Sterile Injectable Drugs Market”, By Type (Small Molecule and Large Molecule), By Therapeutic Application (Cancer, Diabetes, Cardiovascular Diseases, Infectious Disorders, Central Nervous Systems, Musculoskeletal, Anti-Viral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - forecast till 2034

The prominent player operating in the global sterile injectable drugs market includes AstraZeneca plc., Novartis AG, Baxter International Inc., Johnson & Johnson, Sanofi S.A., Pfizer Inc., GlaxoSmithKline plc., Gilead Sciences, Inc., Merck & Co., Inc., and Nova Nordisk A/S.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions development company that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. 

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com